Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China

References

• Migliori GB, Tiberi S, Zumla A, et al. MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int J Infect Dis. 2020;92S:S15–S25. doi:10.1016/j.ijid.2020.01.042
   PubMedGoogle Scholar
• Li Q, Lu M, Hsieh E, et al. Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: a retrospective cohort study. Medicine. 2020;99(50):e23649. doi:10.1097/MD.0000000000023649
   PubMed Web of Science ®Google Scholar
• Cheng N, Wu S, Luo X, et al. A comparative study of chest computed tomography findings: 1030 cases of drug-sensitive tuberculosis versus 516 cases of drug-resistant tuberculosis. Infect Drug Resist. 2021;14:1115–1128. doi:10.2147/IDR.S300754
   PubMed Web of Science ®Google Scholar
• Carter DJ, Glaziou P, Lonnroth K, et al. The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1. Lancet Glob Health. 2018;6(5):e514–e522. doi:10.1016/S2214-109X(18)30195-5
   PubMed Web of Science ®Google Scholar
• Gao W, Chen X, Yao L, et al. Drug Resistance of Mycobacterium tuberculosis Based on Whole-Genome Sequencing in the Yi Ethnic Group, Sichuan Province, China. J Immunol Res. 2023;2023:4431209. doi:10.1155/2023/4431209
   PubMed Web of Science ®Google Scholar
• World Health Organization: Global tuberculosis report 2022. Available from: https://www.who.int/publications/m/item/global-tuberculosis-report-2022-factsheet. Accessed November 1, 2023.
   Google Scholar
• Li D, He W, Chen B, Lv P. Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: comparisons of CT findings. PLoS One. 2017;12(6):e176354.
   Web of Science ®Google Scholar
• Chuchottaworn C, Thanachartwet V, Sangsayunh P, et al. Risk factors for multidrug-resistant tuberculosis among patients with pulmonary tuberculosis at the Central Chest Institute of Thailand. PLoS One. 2015;10(10):e139986. doi:10.1371/journal.pone.0139986
   Web of Science ®Google Scholar
• Bhering M, Kritski A. Primary and acquired multidrug-resistant tuberculosis: predictive factors for unfavorable treatment outcomes in Rio de Janeiro, 2000–2016. Revista Panamericana de Salud Pública. 2020;44(1):178. doi:10.26633/RPSP.2020.178
   Google Scholar
• Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infect Drug Resist. 2017;10:185–192. doi:10.2147/IDR.S135935
   PubMed Web of Science ®Google Scholar
• Sasikumar C, Utpat K, Desai U, Joshi J. The role of genexpert in the diagnosis of Mycobacterium tuberculosis. Adv Respir med. 2020;88(3):183–188. doi:10.5603/ARM.2020.0102
   PubMed Web of Science ®Google Scholar
• Hu L, Zhu W, Yu J, et al. Family-based improvement for health literacy among the Yi nationality (FAMILY) inLiangshan: protocol of an open cohort stepped wedge cluster randomized controlled trial. BMC Public Health. 2022;22(1):1543. doi:10.1186/s12889-022-13782-w
   PubMed Web of Science ®Google Scholar
• Wang H, Liao R, Chen X, et al. How to improve the COVID-19 health education strategy in impoverished regions: a pilot study. Infect Dis Poverty. 2022;11(1). doi:10.1186/s40249-022-00963-3
   Web of Science ®Google Scholar
• Liu X, Zhao W, Hu F, et al. Comorbid anxiety and depression, depression, and anxiety in comparison in multi-ethnic community of west China: prevalence, metabolic profile, and related factors. J Affect Disord. 2022;298(Pt A):381–387. doi:10.1016/j.jad.2021.10.083
   PubMedGoogle Scholar
• Yang Q, Zhang R, Gao Y, et al. Computed tomography findings in patients with pulmonary tuberculosis and diabetes at an infectious disease hospital in China: a retrospective cross-sectional study. BMC Infect Dis. 2023;23(1):436. doi:10.1186/s12879-023-08386-7
   PubMed Web of Science ®Google Scholar
• Xia LL, Li SF, Shao K, Zhang X, Huang S. The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis. Infect Drug Resist. 2018;11:187–193. doi:10.2147/IDR.S146741
   PubMed Web of Science ®Google Scholar
• Lyu M, Wang D, Zhao J, et al. A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus. Int J Infect Dis. 2020;97:69–77. doi:10.1016/j.ijid.2020.05.080
   PubMed Web of Science ®Google Scholar
• Shin HS, Choi DS, Na JB, et al. Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: a comparison with primary drug sensitive tuberculosis. PLoS One. 2020;15(10):e239431. doi:10.1371/journal.pone.0239431
   Web of Science ®Google Scholar
• Xu L, Xu S. CT imaging characteristics of nontuberculous mycobacteria lung disease, active tuberculosis and multi-drug resistant tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(2):e2022008. doi:10.36141/svdld.v39i2.11829
   PubMed Web of Science ®Google Scholar
• Lawal IO, Mokoala KMG, Mathebula M, et al. Correlation between CT features of active tuberculosis and residual metabolic activity on end-of-treatment FDG PET/CT in patients treated for pulmonary tuberculosis. Front Med. 2022;9:791653. doi:10.3389/fmed.2022.791653
   Web of Science ®Google Scholar
• Cha J, Lee HY, Lee KS, et al. Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis. Korean J Radiol. 2009;10(3):207–216. doi:10.3348/kjr.2009.10.3.207
   PubMed Web of Science ®Google Scholar
• Wáng YXJ, Chung MJ, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M. Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences. Quant Imag Med Surg. 2018;8(2):161–173. doi:10.21037/qims.2018.03.06
   PubMed Web of Science ®Google Scholar
• Shin SS, Keshavjee S, Gelmanova IY, et al. Development of extensively drug-resistant tuberculosis during Multidrug-resistant tuberculosis treatment. Am J Resp Crit Care. 2010;182(3):426–432. doi:10.1164/rccm.200911-1768OC
   PubMed Web of Science ®Google Scholar
• Song QS, Zheng CJ, Wang KP, et al. Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: a computerized tomography study with history length matched cases. J Thorac Dis. 2022;14(7):2522. doi:10.21037/jtd-22-145
   PubMedGoogle Scholar